Yıl: 2015 Cilt: 16 Sayı: 1 Sayfa Aralığı: 1 - 9 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Tuberculous Pleural Effusion

Öz:
Hasta yeni bir plevral effüzyon ile başvurduğunda tüberküloz plö- rezi tanısı düşünülmelidir. Eğer tanı konulmazsa hasta akciğer veya akciğer dışı tüberküloz gelişmesi riski altındadır. Tüberkülozlu hastaların %3 ila %25i tüberküloz plörezi geçirecektir. Tüberküloz plörezi insidansı HIV pozitif hastalarda daha yüksektir. Plevra sıvısı genellikle lenfosit hakimiyeti olan bir eksüdadır. Lenfositik plevral effüzyonlu bir hastada tüberküloz plörezi tanısı koymanın en kolay yolu 40 U/L üzerinde bir plevra sıvısı adenozin deaminaz seviyesini göstermektir. Tüberküloz plörezi tedavisi akciğer tüberkülozu tedavisiyle aynıdır. Tüberküloz ampiyemi nadir bir oluşumdur ve tedavisi güçtür.
Anahtar Kelime:

Konular: Cerrahi

Tüberküloz Plevral Effüzyon

Öz:
When a patient presents with new pleural effusion, the diagnosis of tuberculous (TB) pleuritis should be considered. The patient is at risk for developing pulmonary or extrapulmonary TB if the diagnosis is not made. Between 3% and 25% of patients with TB will have TB pleuritis. The incidence of TB pleuritis is higher in patients who are human immunodeficiency virus (HIV)-positive. Pleural fluid is an exudate that usually has a predominance of lymphocytes. The easiest way to diagnose TB pleuritis in a patient with lymphocytic pleural effusion is to demonstrate a pleural fluid adenosine deaminase level above 40 IU/L. The treatment for TB pleuritis is the same as that for pulmonary TB. Tuberculous empyema is a rare occurrence, and the treatment is difficult
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Porcel JM. Tuberculous pleural effusion. Lung 2009;187:263- 70. [CrossRef]
  • 2. Moudgil H, Sridhar G, Leitch AG. Reactivation disease: the commonest forms of tuberculous pleural effusion in Edinburgh. 1980-1991. Respir Med 1994;88:301-4. [CrossRef]
  • 3. Epstein DM, Lewis LR, Alberta SM, Miller WT. Tuberculous pleural effusions. Chest 1987;91:106-9. [CrossRef]
  • 4. Ong A, Creasman J, Hopewell PC, et al. A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin Infect Dis 2004;38:25-31. [CrossRef]
  • 5. Qiu L, Teeter LD, Liu Z, et al. Diagnostic associations between pleural and pulmonary tuberculosis. J Infect 2006;53:377-86. [CrossRef]
  • 6. Torgersen J, Dorman SE, Baruch N, et al. Molecular epidemiology of pleural and other extrapulmonary tuberculosis: a Maryland state review. Clin Infect Dis 2006;42:1375-82. [CrossRef]
  • 7. Yone EW, Kenge AP, Moifo B, et al. Prevalence and determinants of extrapulmonary TB involvement in patients with pulmonary tuberculosis in a Sub-Saharan African country: a cross-sectional study. Scand J Infect Dis 2013;45:104-11. [CrossRef]
  • 8. Berger HW, Mejia E. Tuberculous pleurisy. Chest 1973;63:88- 92. [CrossRef]
  • 9. Stead WW, Eichenholz A, Strauss HK. Operative and pathologic findings in twenty-four patients with syndrome of idiopathic pleurisy with effusion, presumably tuberculosis. Am Rev Tuberc 1955;71:473-502.
  • 10. Leibowitz S, Kennedy L, Lessof MH. The tuberculin reaction in the pleural cavity and its suppression by antilymphocyte serum. Br J Exp Pathol 1973;54:152-62.
  • 11. Antony VB, Repine JE, Harada RN, et al. Inflammatory responses in experimental tuberculosis pleurisy. Acta Cytol 1985;27:355.
  • 12. Antony VB, Sahn SA, Antony AC, et al. Bacillus CalmetteGuerin-stimulated neutrophils release chemotaxins for monocytes in rabbit pleural space in vitro. J Clin Invest 1985;76:1514-21. [CrossRef]
  • 13. Valdes L, Ferreiro L, Cruz-Ferro E, et al. Recent epidemiologic trends in tuberculous pleural effusion in Galicia, Spain. Eur J Intern Med 2012;23:727-32. [CrossRef]
  • 14. Baumann MH, Nolan R, Petrini M, et al. Epidemiology of pleural tuberculosis in the United States: incidence and drug resistance. Chest 2007;131:1125-32. [CrossRef]
  • 15. Light RW. Pleural Diseases, 5th ed. Lippincott, Williams and Wilkins, Baltimore, MD, 2007.
  • 16. Aljohaney A, Amjadi K, Alvarez GG. A systematic review of the epidemiology, immunopathogenesis, diagnosis, and treatment of Pleural TB in HIV infected patients. Clin Dev Immunol 2012;2012:842045. [CrossRef]
  • 17. Saks AM, Posner R. Tuberculosis in HIV positive patients in South Africa: a comparative radiological stud with HIV negative patients. Clin Radiol 1992;46:387-90. [CrossRef]
  • 18. Awil PO, Bowlin SJ, Daniel TM. Radiology of pulmonary tuberculosis and human immunodeficiency virus infection in Gulu, Uganda. Eur Respir J 1997;10:615-8.
  • 19. Levine H, Szanto PB, Cugell DW. Tuberculous pleurisy: an acute illness. Arch Intern Med 1968;122:329-32. [CrossRef]
  • 20. Ozvaran MK, Baran R, Tor M, et al. Extrapulmonary tuberculosis in non-human immunodeficiency virus-infected adults in an endemic region. Ann Thor Med 2007;3:118-21. [CrossRef]
  • 21. Valdes L, Alvarez D, San Jose E, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med 1998;158:2017-21. [CrossRef]
  • 22. Porcel JM, Vives M. Etiology and pleural fluid characteristics of large and massive pleural effusions. Chest 2003;124:978-83. [CrossRef]
  • 23. Seiscento M, Vargas FS, Bombarda S, et al. Pulmonary involvement in pleural tuberculosis: How often does it mean disease activity? Respir Med 2011;105:1079-83. [CrossRef]
  • 24. Kim HJ, Lee HJ, Kwon SY, et al. The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis. Chest 2006;129:1253-8. [CrossRef]
  • 25. Ariyurek OM, Cil BE. Atypical presentation of pleural tuberculosis: CT findings. Br J Radiol 2000;73:209-10. [CrossRef]
  • 26. Heyderman RS, Makunike R, Muza T, et al. Pleural tuberculosis in Harare, Zimbabwe: the relationship between human immunodeficiency virus, CD4 lymphocyte count, granuloma formation and disseminated disease. Trop Med Int Health 1998;3:14-20. [CrossRef]
  • 27. Patalia J. Initial tuberculous pleuritis in the Finnish Armed Forces in 1939-1945 with special reference to eventual post pleurtic tuberculosis. Acta Tuberc Scand 1954;36:1-57.
  • 28. Roper WH, Waring JJ. Primary serofibrinous pleural effusion in military personnel. Am Rev Tuberc 1955;71:616-34.
  • 29. Tiemersma EW, van der Welf MJ, Borgdorff MW, et al. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One 2011;4:e17601. [CrossRef]
  • 30. Kobashi Y, Abe M, Mourie K, et al. Usefulness of tuberculin skin test and three interferon-gamma release assays for the differential diagnosis of pulmonary tuberculosis. Intern Med 2012;10:1199-205. [CrossRef]
  • 31. Chan CH, Alrnold M, Chan CY, et al. Clinical and pathological features of tuberculous pleural effusion and its long term consequences. Respiration 1991;58:171-5. [CrossRef]
  • 32. Yam LT. Diagnostic significance of lymphocytes in pleural effusions. Ann Intern Med 1967;66:972-82. [CrossRef]
  • 33. Light RW, Erozan YS, Ball WC. Cells in pleural fluid: their value in differential diagnosis. Arch Intern Med 1973;132:2854-60. [CrossRef]
  • 34. Spriggs AI, Boddington MM. The Cytology of Effusions. 2nd edn. Grune & Stratton, New York, 1968.
  • 35. Hurwitz S, Leiman G, Shapiro C. Mesothelial cells in pleural fluid: TB or not TB? S Afr Med J 1980;57:937-9.
  • 36. Jones D, Lieb T, Narita M, et al. Mesothelial cells in pleural effusions of HIV-infected patients. Chest 2000;117:289-91. [CrossRef]
  • 37. Porcel JM. Pleural fluid biomarkers: beyond the light criteria. Clin Chest Med 2013;1:27-37. [CrossRef]
  • 38. Perez-Rodriguez E, Castro DJ. The use of ADA and ADA isoenzymes in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Dis 2000;6:259-66. [CrossRef]
  • 39. Ocana I, Martinez-Vasquez JM, Segura RM, et al. Adenosine deaminase in pleural fluids: test for diagnosis of tuberculous pleural effusion. Chest 1983;84:51-3. [CrossRef]
  • 40. Garcia-Zamalloa A, Taboada-Gomez J. Diagnostic accuracy of adenosine deaminase and lymphocyte proportion in pleural fluid for tuberculous pleurisy in different prevalence scenarios. PLoS One 2012;7:e38729. [CrossRef]
  • 41. Liang QL, Shi HZ, Wang K, et al. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 2008;102:744-54. [CrossRef]
  • 42. Baba K, Hoosen AA, Langeland N, et al. Adenosine deaminase activity is a sensitive maker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts. PLoS One 2008;3:e2788. [CrossRef]
  • 43. Tarhan G, Gumuslu F, Yilmaz N, et al. Serum adenosine deaminase and platelet factor 4 activities in active pulomonary tuberculosis, HIV-seropositive subjects, and cancer patients. J Infect 2006;52:264-8. [CrossRef]
  • 44. Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in plueral fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med 2010;21:419-23. [CrossRef]
  • 45. Porcel JM. Tuberculous pleural effusion. Lung 2009;187:263-70. [CrossRef]
  • 46. Ferrer JS, Munoz XG, Orriols RM, et al. Evolution of idiopathic pleural effusion. A prospective, long-term follow-up study. Chest 1996;109:1508-13. [CrossRef]
  • 47. Jimenez CD, Diaz NG, Perez-Rodriguez E, et al. Diagnostic value of adenosine deaminase in nontuberculosis lymphocytic pleural effusions. Eur Respir J 2003;21:220-4. [CrossRef]
  • 48. Villena V, Lopez-Encuentra A, Pozo F, et al. Interferon gamma levels in pleural fluid for the diagnosis of tuberculosis. Am J Med 2003;115:365-70. [CrossRef]
  • 49. Jiang J, Shi HZ, Liang QL, et al. Diagnostic value of interferon-gamma in tuberculous pleurisy: a meta-analysis. Chest 2007;131:1133-41. [CrossRef]
  • 50. Greco S, Girardi E, Masciangelo R, et al. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis 2003;7:777-86.
  • 51. Zhou Q, Chen YQ, Qin SM, et al. Diagnostic accuracy of Tcell interferon-γ release assays in tuberculous pleurisy: a metaanalysis. Respir 2011;3:437-80.
  • 52. Chegou NN, Walzl G, Bollinger CT, et al. Evaluation of adapted whole-blood interferon-gamma release assays for the diagnosis of pleural tuberculosis. Respiration. 2008;76:131-8. [CrossRef]
  • 53. Hooper C, Lee YCG, Masell NA. Inteferon gamma release assays for the diagnosis of TB pleural effusions: hype or recall hope? Curr Opin Pulm Dis 2009;15:358-65. [CrossRef] 54. CDC. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR 2009;58:7- 10.
  • 55. Davis JL, Huang L, Worodria W, et al. Nucleic acid amplification tests for the diagnosis of smear-negative TB in a high HIV-prevalence setting: a prospective cohort study. PLoS One 2011;6:e16321. [CrossRef]
  • 56. Dinnes J, Deeks J, Kunst H, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 2007;11:1-196. [CrossRef]
  • 57. El-Hajj HH, Marras SA, Tyagi S, et al. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol 2001;39:4131-7. [CrossRef]
  • 58. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. NEJM 2010;363:1005-15. [CrossRef]
  • 59. Hillmann D, Rusch-Gerdes S, Boehme CC, et al. Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System. J Clin Microbio 2011;49:1202-5. [CrossRef]
  • 60. Conde MB, Loivos AC, Rezende VM, et al. Yield of sputum induction in the diagnosis of pleural tuberculosis. Am J Respir Crit Care Med 2003;167:723-5. [CrossRef]
  • 61. Escudero BC, Garcia CM, Cuesta CB, et al. Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope’s needle. Study of 414 patients. Arch Intern Med 1990;150:1190-4. [CrossRef]
  • 62. Maartens G, Bateman ED. Tuberculous pleural effusions: increased culture yield with bedside inoculation of the pleural fluid and poor diagnostic value of adenosine deaminase. Thorax 1991;46:96-9. [CrossRef]
  • 63. Luzze H, Elliot AM, Joloba ML, et al. Evaluation of suspected tuberculous pleurisy: clinical and diagnostic findings in HIV- 1-positive and HIV-negative adults in Uganda. Int J Tuberc Lung Dis 2001;5:746-53.
  • 64. Diacon H, Van de Wal BW, Wyser C, et al. Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur Respir J 2003;22:589-91. [CrossRef]
  • 65. Small PM, Fujiwara PI. Management of tuberculosis in the United States. N. Eng J Med 2001;345:189-200. [CrossRef]
  • 66. Blumberg HM, Buman WJ, Chaisson RE, et al. American Thoracic Society/Center for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62. [CrossRef]
  • 67. Canete C, Galarza I, Granados A, et al. Tuberculous pleural effusions: experience with six months of treatment with isoniazid and rifampicin. Thorax 1994;49:1160-1. [CrossRef]
  • 68. Dutt AK, Moers D, Stead WW. Tuberculous pleural effusion: 6-month therapy with isoniazid and rifampin. Am Rev Respir Dis 1992;145:1429-32. [CrossRef]
  • 69. Tani P, Poppins H, Maekipaja J. Cortisone therapy for exudative tuberculous pleurisy in the light of a follow-up study. Acta Tuberc Pneumol Scand 1964;44:303-9.
  • 70. Galarza I, Canete C, Granados A, et al. Randomised trial of corticosteroids in the treatment of tuberculous pleurisy. Thorax 1995;50:1305-7. [CrossRef]
  • 71. Wyser C, Walzl G, Smedema IP, et al. Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study. Chest 1996;110:333-8. [CrossRef]
  • 72. Barbas CS, Cukier A, de Varvalho CR, et al. The relationship between pleural fluid findings and the development of pleural fluid thickening in patients with pleural tuberculosis. Chest 1991;100:1264-7. [CrossRef]
  • 73. Candela A, Andujar J, Hernandez L, et al. Functional sequelae of tuberculous pleurisy in patients correctly treated. Chest 2003;123:1996-2000. [CrossRef]
  • 74. Wong PC. Management of tuberculous pleuritis: can we do better? Respirology 2005;10:144-8. [CrossRef]
  • 75. Zhou A, Guo L, Tang L. Effect of an intrathoracic injection of sodium hyaluronic acid on the prevention of pleural thickening in excess fluid of tuberculous thoracic cavity. Clin Exp Pharmacol Physiol 2003;30:203-5. [CrossRef]
  • 76. Han DH, Song JW, Chung HS, et al. Resolution of residual pleural disease according to time course in tuberculous pleurisy
  • during and after the termination of antituberculosis medication. Chest 2005;128:3240-5. [CrossRef]
  • 77. Lai YF, Chao TY, Wang YH, et al. Pigtail drainage in the treatment of tuberculous pleural effusions: a randomized study. Thorax 2003;58:149-51. [CrossRef]
  • 78. Kwak SM, Park CS, Cho JH, et al. The effects of urokinase instillation therapy via percutaneous transthoracic catheter in loculated tuberculous pleural effusions: a randomized prospective study. Yonsei Med J 2004;45:822-8. [CrossRef]
  • 79. Al-Majed SA. Study of paradoxical response to chemotherapy in tuberculous pleural effusion. Respir Med 1996;90:211-4. [CrossRef]
  • 80. Choi YW, Jeon SC, Seo HS, et al. Tuberculous pleural effusion: new pulmonary lesions during treatment. Radiology 2002;224:493-502. [CrossRef]
  • 81. Gupta RC, Dixit R, Purohit SD, et al. Development of pleural effusion in patients during anti-tuberculous chemotherapy: analysis of twenty-nine cases with review of literature. Indian J Chest Dis Allied Sci 2000;42:161-6.
  • 82. Lee CH, Wang WJ, Lan RS, et al. Corticosteroids in the treatment of tuberculous pleurisy: a double blinded, placebo-controlled, randomized study. Chest 1988;94:1256-9. [CrossRef]
  • 83. Elliott AM, Luzze H, Quigley MA, et al. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculousis. J Infect Dis 2004;190:869-78. [CrossRef]
  • 84. Engel ME, Matchaba PT, Volmink J. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev 2007:CD001876.
  • 85. Sahn SA, Iseman MD. Tuberculous empyema. Semin Respir Infect 1999;14:82-7. 86. Mancini P, Mazzei L, Zarzana A, et al. Post-tuberculosis chronic empyema of the “fourty years after.” Eur Rev Med Pharmacol Sci 1998;2:25-9.
  • 87. Jover F, Andreu L, Cuadrado JM, et al. Tuberculous empyema necessitatis in a man infected with human immunodeficiency virus. South Med J 2002;95:751-2. [CrossRef]
  • 88. Neihart RE, Hof DG. Successful nonsurgical treatment of tuberculous empyema in an irreducible pleural space. Chest 1985;88:792-4. [CrossRef]
  • 89. Iseman MD, Madsen LA. Chronic tuberculous empyema with bronchopleural fistula resulting in treatment failure and progressive drug resistance. Chest 1991;100:124-7. [CrossRef]
  • 90. Greco S, Girardi E, Masciangelo R, et al. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculosis pleural effusion: a cost-effectiveness analysis. J Clin Lab Anal 2005;19:40-6. [CrossRef]
APA COHEN L, LIGHT R (2015). Tuberculous Pleural Effusion. , 1 - 9.
Chicago COHEN Leah A.,LIGHT Richard W. Tuberculous Pleural Effusion. (2015): 1 - 9.
MLA COHEN Leah A.,LIGHT Richard W. Tuberculous Pleural Effusion. , 2015, ss.1 - 9.
AMA COHEN L,LIGHT R Tuberculous Pleural Effusion. . 2015; 1 - 9.
Vancouver COHEN L,LIGHT R Tuberculous Pleural Effusion. . 2015; 1 - 9.
IEEE COHEN L,LIGHT R "Tuberculous Pleural Effusion." , ss.1 - 9, 2015.
ISNAD COHEN, Leah A. - LIGHT, Richard W.. "Tuberculous Pleural Effusion". (2015), 1-9.
APA COHEN L, LIGHT R (2015). Tuberculous Pleural Effusion. Turkish Thoracic Journal, 16(1), 1 - 9.
Chicago COHEN Leah A.,LIGHT Richard W. Tuberculous Pleural Effusion. Turkish Thoracic Journal 16, no.1 (2015): 1 - 9.
MLA COHEN Leah A.,LIGHT Richard W. Tuberculous Pleural Effusion. Turkish Thoracic Journal, vol.16, no.1, 2015, ss.1 - 9.
AMA COHEN L,LIGHT R Tuberculous Pleural Effusion. Turkish Thoracic Journal. 2015; 16(1): 1 - 9.
Vancouver COHEN L,LIGHT R Tuberculous Pleural Effusion. Turkish Thoracic Journal. 2015; 16(1): 1 - 9.
IEEE COHEN L,LIGHT R "Tuberculous Pleural Effusion." Turkish Thoracic Journal, 16, ss.1 - 9, 2015.
ISNAD COHEN, Leah A. - LIGHT, Richard W.. "Tuberculous Pleural Effusion". Turkish Thoracic Journal 16/1 (2015), 1-9.